Alnylam Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €8.04B +17.7% €2.66B +20.5% 33.0% +0.0075 pp €6.11B +70.7% 75.9% +0.24 pp
    (estimated) €6.83B +22.6% €2.21B +47.2% 32.3% +0.054 pp €3.58B +52.5% 52.4% +0.10 pp
    (estimated) €5.57B +30.1% €1.50B +130.3% 26.9% +0.12 pp €2.35B +83.0% 42.1% +0.12 pp
    (estimated) €4.29B +42.2% €650.64M +380.8% 15.2% +0.11 pp €1.28B +201.8% 29.9% +0.16 pp
    (estimated) €3.01B +57.1% €135.32M -157.0% 4.5% +0.17 pp €424.80M +1,818.1% 14.1% +0.13 pp
    €1.92B +23.0% -€237.25M -36.8% -12.4% +0.12 pp €22.15M -84.4% 1.2% -0.079 pp
    €1.56B +76.2% -€375.50M -61.1% -24.1% +0.85 pp €141.90M -135.5% 9.1% +0.54 pp
    €884.87M +22.9% -€964.82M +32.6% -109.0% -0.080 pp -€400.22M -17.0% -45.2% +0.22 pp
    €720.14M +71.3% -€727.42M -0.6% -101.0% +0.73 pp -€482.19M +3.8% -67.0% +0.44 pp
    €420.38M +124.3% -€732.07M -3.1% -174.1% +2.3 pp -€464.52M +293.9% -110.5% -0.48 pp
    €187.44M +193.4% -€755.81M +16.4% -403.2% +6.1 pp -€117.94M -68.3% -62.9% +5.2 pp
    €63.89M -16.7% -€649.52M +55.1% -1,016.6% -4.7 pp -€371.66M +56.4% -581.7% -2.7 pp
    €76.69M +90.7% -€418.69M +19.7% -545.9% +3.2 pp -€237.61M +14.6% -309.8% +2.1 pp
    €40.22M +14.8% -€349.80M +41.4% -869.6% -1.6 pp -€207.39M +38.0% -515.6% -0.87 pp
    €35.05M -18.7% -€247.42M -19.5% -705.8% +0.070 pp -€150.28M +12.5% -428.7% -1.2 pp
    €43.13M +7.2% -€307.40M +303.9% -712.8% -5.2 pp -€133.64M +142.3% -309.9% -1.7 pp
    €40.23M -29.3% -€76.10M -15.8% -189.2% -0.30 pp -€55.14M -39.7% -137.1% +0.24 pp
    €56.91M -19.4% -€90.42M +83.9% -158.9% -0.89 pp -€91.49M +25.0% -160.8% -0.57 pp
    €70.59M -17.3% -€49.17M +32.5% -69.7% -0.26 pp -€73.16M +7.7% -103.6% -0.24 pp
    €85.33M -0.5% -€37.12M -8.6% -43.5% +0.038 pp -€67.90M +18.5% -79.6% -0.13 pp
    €85.75M +4.5% -€40.59M +81.3% -47.3% -0.20 pp -€57.31M -188.1% -66.8% -1.5 pp
    €82.02M +88.9% -€22.39M -69.3% -27.3% +1.4 pp €65.04M -62.7% 79.3% -3.2 pp
    €43.41M +89.0% -€72.90M +147.0% -167.9% -0.39 pp €174.26M -1,140.0% 401.4% +4.7 pp
    €22.97M +371.1% -€29.52M -19.4% -128.5% +6.2 pp -€16.76M +35.1% -72.9% +1.8 pp
    €4.88M +33.6% -€36.60M +31.4% -750.8% +0.13 pp -€12.40M +37.6% -254.3% -0.074 pp
    €3.65M +2,330.7% -€27.85M +30.4% -763.3% +130 pp -€9.01M +8.8% -246.9% +53 pp
    €150.12K +∞% -€21.35M +505.2% -14,223.3% -140 pp -€8.28M +1,256.0% -5,516.5% -55 pp
    €0.00 -€3.53M N/A -€610.71K N/A

    Notifications